tirzepatide fda submission Grants a New Indication for Obesity Management Novel, Dual-Targeted Treatment for T2D
Description
Both contain the drug semaglutide, but at different doses and for different purposes

Some people find that injecting in the morning rather than the evening minimizes nighttime GI discomfort

Document consent, counselling and outcomes in the patient record

Food and Drug Administration (FDA), compounded medications are not approved by the FDA for quality, safety, or effectiveness

NSAIDs can increase the risk of gastrointestinal irritation, which may compound existing GI side effects from tirzepatide including constipation and nausea

The Danish drugmaker Novo Nordisk said Monday the medications cost $499 at Costco pharmacies for self-pay Costco members
